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وبائيات متالزمة الشريان التاجي احلادة يف سلطنة عمان
نتائج دراسة عمان- ريس
جواد اأحمد اللواتي، كاظم جعفر �صليمان، برا�صانت بندوغرا
مت  التي  البيانات  حتليل  املنهجية:  عمان.  �صلطنة  يف  احلادة  التاجي  ال�رسيان  ملتالزمة  اخلطر  وعوامل  وبائية  تقييم  الهدف:  امللخ�ص: 
جمعها من خالل درا�صة متعددة املراكز يف عدة دول، بني املر�صى اللذين اأدخلوا على التوايل اىل امل�صايف والذين ترتاوح اأعمارهم 20 
اأو اأكرث بت�صخي�ض متالزمة ال�رسيان التاجي احلادة يف خم�ض من دول اخلليج العربي )عمان والبحرين والكويت وقطر والإمارات  عاما 
العربية املتحدة(، واليمن على مدى فرتة 5 اأ�صهر. هذا التحليل يلخ�ض بيانات املر�صى العمانيني الذين اأدخلوا امل�صت�صفى بت�صخي�ض مبدئي 
مبتالزمة ال�رسيان التاجي احلادة. النتائج: مت تاأكيد 1,340 حالة ملتالزمة ال�رسيان التاجي احلادة منها 748 بني الرجال 592 بني 
الن�صاء حيث بلغ العمر الو�صيط 61 �صنة. وكان معدل الإ�صابة للمتالزمة 338.9 حالة لكل 100,000 �صخ�ض- �صنة. بينما بلغت 779 و 
674 حالة لكل100,000 �صخ�ض- �صنة بني الرجال والن�صاء على التوايل. وكان ن�صبة الذكور اإىل الإناث اأعلى بني مر�صى اإرتفاع مقطع 
 ST )فى ر�صم قلب الإحت�صاء التجلطى )2.26، بفا�صل ثقة %95  1.63 اىل 3.15( ويليه اإحت�صاء ع�صلة القلب غري املرتبط مبقطع ST
0.99(. و�صكلت  %95 0.66 اىل  اىل 2.21(، والذبحة ال�صدرية غري امل�صتقرة )0.79 بفا�صل ثقة   1.28 95% 86.1، بفا�صل ثقة 
الذبحة ال�صدرية غري امل�صتقرة %55 من احلالت، واإحت�صاء ع�صلة القلب الناجم عن ارتفاع مقطع ST %26 واإحت�صاء ع�صلة القلب غري 
الدم  ارتفاع �صغط  انت�صار  التاجيزيادة معدل  ال�رسيان  ST 19% من احلالت. من بني عوامل خطرالأ�صابة مبتالزمة  املرتبط مبقطع 
)%68( وداء ال�صكري )%36(، وارتفاع الدهون )%63( وزيادة الوزن / ال�صمنة )%65(، مع معدل منخف�ض ن�صبيا من ا�صتخدام التبغ يف 
الوقت احلا�رس )%11( واخلال�صة: درا�صتنا توؤكد حدوث معدلت مرتفعة ملتالزمة ال�رسيان التاجي احلادة بني العمانيني ويدعم فكرة اأن 
وباء مر�ض القلب والأوعية الدموية جتتاح البلدان النامية.
مفتاح الكلمات: متالزمة ال�رسيان التاجي احلادة، اأمرا�ض القلب والأوعية الدموية، نق�ض تروية القلب، عوامل اخلطر، و�صلطنة عمان.
abstract: Objectives: This study aimed to evaluate the epidemiology and coronary risk factors of acute coronary 
syndrome (ACS) in Oman. Methods: Data were collected through a prospective, multinational, multicentre survey 
of consecutive patients, hospitalised over a 5-month period in 2007 with a diagnosis of ACS, in Yemen and five 
Arabian Gulf countries (Oman, Bahrain, Kuwait, Qatar, United Arab Emirates). Here we present data of Omani 
patients aged ≥20 years who received a provisional diagnosis of ACS and were consequently admitted to 14 different 
hospitals. Results: There where 1,340 confirmed ACS episodes in 748 men and 592 women (median age 61 years). 
The overall crude incidence rate of ACS was 338.9 per 100,000 person-years (P-Y). The age-standardised rate (ASR) 
of ACS was 779 and 674 per 100,000 P-Y for men and women, respectively. The ASR male-to-female rate ratio was 
highest in the ST-elevation myocardial infarction (STEMI) group (2.26, 95% confidence interval ([CI], 1.63 to 3.15) 
followed by the non-STEMI (NSTEMI) group (1.68, 95% CI 1.28 to 2.21) and unstable angina (0.79, 95% CI 0.66 to 
0.99). Unstable angina accounted for 55%, STEMI for 26% and NSTEMI for 19% of ACS cases. Among the coronary 
risk factors, there was a high prevalence of hypertension (68%), diabetes mellitus (DM) (36%), hyperlipidaemia 
(63%), and overweight/obesity (65%), with a relatively low rate of current tobacco use (11%). Conclusion: Our study 
confirms a high incidence of ACS in Omanis and supports the notion that the cardiovascular disease epidemic is 
also sweeping developing countries.
Keywords: Acute coronary syndrome; Incidence; Cardiovascular disease; Ischemic heart disease; Risk factors; 
Oman.
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Advances in knowledge 
- This paper provides nationwide population-based incidence rates of acute coronary syndrome in a large prospective cohort recruited 
from multiple centres in Oman.
- A comparable methodology was used, assessing the Omani population against other Arab Gulf states, and based upon an international 
comparison with other Arab, Asian, and European populations.
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Current evidence indicates that cardiovascular diseases (CVD) make the largest contribution to mortality in most 
developing countries.1 Of all CVD, ischaemic heart 
disease (IHD) is the single largest cause of death 
in such nations.2 Worldwide, IHD was the second 
and third leading cause of disability-adjusted life 
years lost in men and women in 2002, respectively.1 
Although rates of IHD have fallen by up to 70% 
in the past three decades in some industrialised 
countries, it is likely to remain as the undisputed 
leading cause of death globally until the year 2030.2,3 
Since the early 1990s, CVDs have been the 
leading cause of in-patient mortality in Oman.4 In 
2006, IHD was Oman’s leading cause of morbidity 
and fourth cause of mortality among patients 
aged 45-60 years.5 Although clinical management 
patterns of acute coronary syndrome (ACS) 
have been reported in Oman,6 to the best of our 
knowledge, the epidemiology of IHD and/or ACS 
has not been studied. Through a joint collaborative 
effort, the Gulf Registry for Acute Coronary Events 
(Gulf RACE) was established in 2006 to study 
such events in five Arabian Gulf countries and 
Yemen.7 The aim of this registry was to estimate 
the incidence of ACS in the participating countries, 
the distribution of CVD risk factors among affected 
patients, and types and practice patterns for 
the management of ACS.7 This study details the 
epidemiology and coronary risk factors of ACS 
patients throughout Oman. 
Methods
The Gulf Registry of Acute Coronary Events (Gulf 
RACE) study was organised as a prospective, 
multinational, multicentre survey of consecutive 
patients over 20 years-old who had been hospitalised 
with the final diagnosis of acute coronary syndrome 
(ACS) in Yemen and five Arabian Gulf countries—
Oman, Bahrain, Kuwait, Qatar, and the United 
Arab Emirates (UAE)—over a period of 6 months. 
The pilot phase lasted throughout May 2006 and is 
described in detail elsewhere.7 Enrolment for the 
study itself commenced on 29 January 2007, and 
continued for 5 months. An attempt was made 
to include all admissions that had been given a 
provisional diagnosis of ACS with no exclusion 
criteria. Patients who were admitted for non-ACS 
causes to general wards but later developed ACS 
in hospital were also included in the study. Of 
the 16 requested centres (15 secondary and one 
tertiary care hospital, all with facilities to manage 
ACS patients), 14 participated in the registry and 
enrolled patients according to the survey’s inclusion 
criteria. The study thus covered at least 85% of the 
total population of Oman. Ethical approval for the 
study was granted by the national or institutional 
ethical bodies in all participating countries.
During the study period, all recruiting hospitals 
managed their patients independently. However, 
patients were referred to Royal Hospital in 
Muscat, the capital of Oman, on an emergency 
basis for primary angiography and/or angioplasty. 
Study forms initiated in the parent institution, or 
secondary care hospital, were sent with patients 
during transfer to the Royal Hospital to complete 
data collection procedures and avoid duplicate 
reporting. All medical services, including ACS 
management, are provided free of charge to Omani 
nationals throughout government institutions in 
the country.
Data collected included patient demographics, 
past medical history, provisional diagnosis on 
admission, final discharge diagnosis, clinical 
features at hospital presentation, electrocardiogram 
(ECG) findings, laboratory investigations, 
medications administered within 24 hours of 
admission and those prescribed on discharge, 
use of cardiac procedures and interventions, in-
hospital outcomes, and in-hospital mortality. All 
management decisions were at the discretion of 
the treating physician. The external auditor visited 
20% of the centres where filled forms and source 
documents (i.e. patients’ case notes) were inspected 
to verify that data collected in the case report form 
matched source documents. No attempt was made 
to validate the accuracy of discharge diagnosis of 
Application to Patient Care
- With the recognition of the high incidence of acute coronary syndrome (ACS) in Oman, the government and public health authorities 
should give higher priority to the control of the underlying cardiovascular disease risk factors which are shown to be highly prevalent in 
Omani patients. 
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the attending physician.
Diagnosis of the different types of ACS and 
definitions of data variables were based on the 
American College of Cardiology clinical data 
standards published in December 2001.8 These 
definitions are based on clinical presentations, ECG 
findings, and cardiac biomarkers. The biomarkers 
were measured locally at each hospital’s laboratory 
using its own assays and reference ranges. Only 
two centres used troponin (T) as routine assays 
in the diagnosis of myocardial injury. Body mass 
index (BMI) was used to characterise overweight 
(BMI 25–29.9 Kg/m2) or obese patients (BMI ≥30 
Kg/m2).9 A waist circumference ≥94 cm in males 
and ≥80 cm in females was considered abnormal. 
Diagnosis of diabetes mellitus (DM) was based 
on past diagnosis by a physician, intake of anti-
diabetic medications, or post-admission fasting 
plasma glucose (FPG) values using the 1999 
diagnostic criteria recommended by the World 
Health Organization (WHO).10 Hypertension was 
diagnosed if systolic and/or diastolic arterial blood 
pressure exceeded 130/85 mmHg, or if a patient 
was on anti-hypertensive medication. Subjects were 
classified as having high total cholesterol if fasting 
levels exceeded 5.2 mmol/L; hypertriglyceridaemia 
if levels exceeded 1.69 mmol/L, and/or abnormal 
levels of high density lipoproteins if levels were 
<1.04 in males and <1.29 mmol/L in females.11
Data were entered in Epi Info, Version 6 (Centers 
for Disease Control, Atlanta, Georgia, USA). 
Categorical variables were presented as a number of 
cases and percentages and compared using the chi-
square test. The K-sample equality-of-medians test 
was used to examine differences between groups of 
median age. Incidence rates of coronary events were 
calculated from index episodes during the study 
period using the mid-year 2007 population estimates 
for Oman obtained from the Omani Ministry of 
National Economy.12 To facilitate comparisons with 
other published rates, age-standardised incidence 
rates (ASR) were calculated by direct method within 
10-year bands for ages 20 years and above, using 
the world standard population.13 For comparisons 
with World Health Organization - Monitoring 
Trends and Determinants in Cardiovascular 
Disease (WHO-MONICA), MONICA age weights 
in the 5-year age bands for ages 35–64 years were 
used.14,15 A 95% confidence interval (CI) for ASR 
ratio (RR) was calculated using the standard error 
of the natural logarithm of the RRs.16 Observed 
differences were expressed as P values. A value of 
P <0.05 was considered statistically significant. 
Analyses were performed with Intercooled Stata, 
version 9.1 (Stata Corporation, Texas, USA) and 
Microsoft Excel 2003 (Microsoft Corporation, 
Redmond, Washington, USA). Completeness of 
data was 98% for all the analysed variables. Patients 
with a diagnosis of left bundle branch block 
(n = 9) were grouped with the ST-elevation 
myocardial infarction (STEMI) patients.
Results
The baseline characteristics of the ACS patients 
enrolled in the study are given in Table 1. Over 
the 153-day recruitment period, 1,340 cases of 
ACS were reported with complete core data. The 
median age of ACS patients was 61 years (males 
60 years and females 61 years; P = 0.39). Among 
the risk factors, a high prevalence of hypertension 
(56%), DM (38.2%), and hyperlipidaemia (36.4%) 
was reported on admission. When fasting blood 
sugar, blood pressure, and total cholesterol were 
measured 24 hours post-admission, there was a 
significant increase in the detection of hypertension 
(56–69%; P <001) and hyperlipidaemia (36.4–63.3%, 
P <001). The prevalence of DM was around 32% 
using random blood sugar, and increased to 46% 
when using fasting plasma glucose levels in patients 
with STEMI (P <001). One-half to two-thirds of 
ACS patients were either overweight or obese 
according to WHO criteria.9 Current tobacco use 
was relatively low (11.1%). 
Of the total ACS patients, 741 (55.3%) were 
discharged from hospitals with unstable angina, 
345 (25.7%) with non-ST elevation myocardial 
infarction (NSTEMI) and 254 (18.9%) with STEMI 
[Table 1]. Unstable angina was also the most 
common diagnosis across all 10-year age strata, 
followed by NSTEMI and STEMI. Patients with 
unstable angina and NSTEMI were also more 
likely to report a medical history of percutaneous 
coronary intervention, DM, hypertension, and 
hyperlipidaemia. On the other hand, STEMI 
patients were more likely to be current tobacco 
users. Women were more likely to present with 
unstable angina compared to men (54% versus 46%, 
P <03) [Table 2], while men were twice as likely to 
present with STEMI and NSTEMI compared to 
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women. 
Table 2 demonstrates the crude and ASR of 
incidence of ACS in Oman in patients aged 20 
years and above, and in a subgroup aged 35–
64 years. The period of case ascertainment (5 
months) encompassed 395,389 person-years (P-Y) 
of observations in 748 men and 592 women (all 
Omanis) with episodes of ACS. The overall crude 
incidence of ACS was 338.9 per 100,000 P-Y. The 
ASR of ACS was 779 and 674 per 100,000 P-Y for 
men and women, respectively. The ASR of ACS 
were significantly higher in men than women with 
Table 1: Baseline characteristics of patients admitted with acute coronary syndrome (Oman RACE study, 2006)








Median age (yrs) 61 61 61 61
Age groups
20–29 0.8 0.6 0.9 0.8
30–39 4.7 4.6 3.5 4.0
40–49 12.6 13.9 13.9 13.7
50–59 22.0 26.1 25.9 25.2
60–69 29.5 33.0 33.3 32.5
70+* 30.3 21.7 22.4 23.7
Men* 73 65 46.0 56.0
Medical history
Angina pectoris* 30.3 52.2 60.9 52.8
MI 16.1 22.6 19.5 19.6
PCI* 3.9 9.0 9.1 8.0
CABG* 3.1 7.0 9.5 7.6
Aspirin use* 31.6 54.2 60.2 53.2
Current tobacco use* 23.6 12.5 6.2 11.1
Diabetes* 30.3 37.4 41.3 38.2
Hypertension* 39.4 55.6 61.8 56.0
Hyperlipidaemia* 23.2 35.6 41.3 36.4
Measurements 24 hours post-admission
RBG ≥ 11.1 mmol/l 32.4 30.7 28.7 29.9
FBG ≥  7.0 mmol/l* 46.0 41.9 30.7 36.5
Hypertension* 61.0 68.0 71.8 68.8
TC >5.2mmol/l 63.3 63.4 63.3 63.3
Abnormal HDL 51.6 57.3 57.7 56.4
Abnormal TG 33.5 30.1 36.8 34.4
BMI 25-29.9 Kg/m2 33.5 40.3 38.3 37.9
BMI ≥30 kg/m2 25.2 26.4 28.9 27.5
Abnormal WC (cm)* 43.7 57.2 66.1 59.8
STEMI = ST-elevation myocardial infarction; NSTEMI = non-ST elevation myocardial infarction; MI = myocardial infarction; PCI = percutaneous 
coronary intervention; CABG = coronary artery bypass graft; RBG = random blood glucose; FBG = fasting blood glucose; TC = total cholesterol; HDL 
= high density lipoprotein; TG = triglycerides; BMI = body mass index; WC = waist circumference.
* = P < 0.05; Chi-square tests were utilised to examine the statistical significance of differences between the respective comparison groups with regards 
to the distribution of categorical variables. A K-sample equality-of-medians test was used to examine between group differences in median age.
For cut-off points for each variable, see Methods section. 
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a rate ratio of 1.16 (95% CI: 1.01 to 1.32). The male 
to female age-standardised incident rate ratio was 
highest in the STEMI group (2.26, 95% CI: 1.63 to 
3.15) followed by the NSTEMI group at 1.68 (95% 
CI: 1.28 to 2.21) and that with unstable angina 
at 0.79. (95% CI: 0.66 to 0.99). When data were 
analysed in a subgroup aged 35–64 years for broad 
comparisons with the MONICA project cohort, 
there were 448 events in males and 350 events in 
females within 128,187 P-Y.14 Age-standardised 
ACS event incident rates were higher in men than 
in women in this age band with a rate ratio of 1.21 
(95% CI: 1.01 to 1.45). 
Discussion
We provide the first age-standardised population-
based incidence rates of ACS and associated risk 
factors in Oman. The ASR of ACS in Omanis (men 
779, women 674 per 100,000 P-Y) were similar to 
rates reported among Palestinian Arabs of Jerusalem 
(796 and 503 per 100,000 men and women P-Y, 
respectively).17 These incidence rates are markedly 
higher than those reported in industrialised 
nations such as Denmark (men 331 and women 
137 per 100,000 P-Y), Greece (both genders 226 
per 100,000 P-Y), and France (men 262 and women 
55 per 100,000 P-Y), thus confirming the double 
burden of already existing communicable diseases 
and the present non-communicable diseases in 
Table 2: Crude and age-standardised annual incidence rates (all per 100,000 person-years) of acute coronary 
syndrome and its components in Omani men and women aged 20 years and above (Oman RACE study, 2006)
Age group All ACS STEMI NSTEMI Unstable Angina 
Male (20+ years)
No. of cases 748 184 224 340
P-Y 198,324 198,324 198,324 198,324
Crude rate (95% CI) 377.2 (350.6 to 405.1) 92.8 (79.9 to 107.2) 112.9 (98.6 to 128.8) 171.4 (153.7 to 190.6)
ASR (95% CI) 779.7 (723.2 to 836.2) 184.9 (164.6 to 221.5) 239.5 (200.5 to 262.3) 355.3 (723.2 to 836.2)
Female (20+ years)
No. of cases 592 70 121 401
P-Y 197,065 197,065 197,065 197,065
All crude (95% CI) 300.4 (276.7 to 325.6) 35.5 (27.7 to 44.9) 61.4 (50.9 to 73.4) 203.5 (184.1 to 224.4)
All ASR (95% CI) 674.3 (619.5 to 729.1) 81.7 (64.1 to 103.8) 142.2 (114.7 to 165.3) 450.4 (619.5 to 729.1)
Male (35-64 years)
No. of cases 448 139 103 206
Person-years 63,543 63,543 63,543 63,543
ASR for ages 35–64 835.0 (757.3 to 912.8) 189.7 (152.6 to 226.8) 256.9 (213.7 to 300.2) 388.3 (335.0 to 441.7)
Females (35-64 yrs)
No. of Cases 350 39 241
P-Y 64,644 64,644 64,644 64,644
ASR for ages 35–64 691.6 (618.7 to 764.5) 81.1 (55.5 to 106.7) 138.9 (106.0 to 171.7) 471.6 (411.4 to 531.7)
Male:Female 
Rate ratio, 20+ 
years (95% CI)
1.16 (1.01 to 1.32) 2.26 (1.63 to 3.15) 1.68 (1.28 to 2.21) 0.79 (0.66 to 0.99)
Rate ratio, 35–64 
years (95% CI)
1.21 (1.01 to 1.45) 2.34 (1.47 to 3.73) 1.85 (1.28 to 2.68) 0.82 (0.65 to 1.05)
ACS = acute coronary syndrome;  STEMI = ST-elevation myocardial infarction;  NSTEMI = Non ST-elevation myocardial infarction; 
P-Y = person-years; ASR = age-standardised rate; CI = confidence interval.
For age-standardising, see reference no. 13.
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middle and low-income developing countries.18–
21Notwithstanding the differences in the definitions 
of coronary events between the present study and 
the MONICA populations studied between 1981 
and 1995, the coronary event incidence rate in 
Omani men aged 35–64 years (835 per 100,000 
P-Y) are comparable to the highest rates recorded 
in the MONICA project (907 per 100,000 P-Y 
among Finnish men).22 Similarly, in the 35–64 
year old cohort, the incidence rate of ACS among 
Omani women (692 per 100,000 P-Y) was more 
than double the rate in their Scottish counterparts 
in the UK (241 per 100,000 P-Y), although, the latter 
was the highest rate reported among MONICA 
women.22 When compared with other Arabs in the 
same age group of 35–64 years, the ACS incidence 
rate among Omanis surpassed the rate reported in 
Palestinian men (799 per 100,000 P-Y) while the 
rate in Omani women was three times the rate in 
Palestinian women (234 per 100,000 P-Y).17
The high incidence of ACS among Omanis (and 
other Arab ethnic groups) may stem from greater 
susceptibility and excess exposure to established 
CVD risk factors.23 In Asian populations, morbidity 
and mortality appear to occur at lower cut-off 
point values for some CVD risk factors such as 
BMI and waist circumference than in Caucasians, 
possibly indicating greater susceptibility at a lower 
threshold for adverse health outcomes.24–26 In our 
study, Omani patients appeared to experience ACS 
at an earlier age (mean 60.7 years; median 61 years) 
than their counterparts from Europe, Australia, 
the United States, and Brazil (median range 63.4–
68.1) by an average of 2 to 7 years.27The difference 
in age can extend up to 11 years if compared 
with Europeans with unstable angina.28 Arab 
patients with ACS from other countries were also 
reported to be younger (mean age: Saudi Arabia 
57.1, Kuwait 56.7, and Palestine 57.9),17,29,30 The 
INTERHEART study also showed Arab patients 
to be a decade younger at presentation with acute 
myocardial infarction than Europeans, Chinese, 
or Latin American patients.31 The earlier onset of 
ACS in Arabs has not been studied systematically. 
However, greater susceptibility to CVD risk factors 
may be implied, in a similar way suspected to occur 
among South Asians through genetic differences or 
a mismatch of metabolic processes during early or 
middle age.23 Other findings like low levels of high 
density lipoproteins and a lack of regular physical 
activity among Omanis may have contributed 
further to their susceptibility to adverse coronary 
outcomes.32
Our study’s main strength lies in the fact that 
it is the first to provide nationwide estimates 
of incidence and risk factors of ACS in a large 
prospective cohort recruited from multiple centres 
in Oman using a methodology comparable with 
other Arab Gulf states. On the other hand, the lack 
of a vital registration system within the country 
implies that sudden cardiac deaths due to ACS could 
not be estimated and thus are not included in the 
current incidence estimates presented here. Further, 
due to limited resources, out of 1,340 patients, T 
assays were used in less than 21% (277 patients) 
to diagnose myocardial injury. However, this is 
unlikely to have biased results towards the under- 
diagnosis of STEMI and NSTEMI as proportions 
of the later two in Oman are similar (42% and 58%, 
respectively) to the overall Gulf-RACE (39% and 
61%, respectively) and Gulf-RACE 2 (46% and 54%, 
respectively) studies after discarding results from 
unstable angina patients.33,34 Finally, comparison 
data were presented with MONICA cohorts in 
spite of changes of some diagnostic criteria and 
temporality between the two studies, mainly due to 
wide use of T assays in the current survey.
Conclusion
The incidence of ACS among Omanis is one of the 
highest in the world and flags up an impending 
CVD epidemic that is yet to reach its peak. The 
need to address root causes of established CVD risk 
factors could not be more urgent.35 Health reforms 
and prevention strategies are needed to counter a 
CVD epidemic, with a particular focus on reducing 
the high number of preventable risk factors.
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